Richard G Pestell

Title: Richard G Pestell: Innovator in Cancer Research

Introduction

Richard G Pestell is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer research, holding a total of 5 patents. His work focuses on innovative methods for understanding and treating cancer, particularly in relation to metastasis.

Latest Patents

One of his latest patents is titled "Use of modulators of CCR5 in the treatment of cancer and cancer metastasis." This patent outlines a method for determining whether a subject with cancer is at risk for developing metastasis. The method involves obtaining a biological sample from the subject, assessing CCR5 expression levels, and identifying those at increased risk based on the findings. Another notable patent is "Prostate cancer cell lines, gene signatures and uses thereof." This patent describes a mammalian prostate cancer cell line that has been genetically modified to express oncogenes. It also details various applications, including methods for assessing metastasis risk and identifying candidate compounds that may inhibit cancer cell proliferation.

Career Highlights

Throughout his career, Richard G Pestell has worked with esteemed institutions, including Albert Einstein College of Medicine. His research has significantly advanced the understanding of cancer biology and treatment options.

Collaborations

Richard has collaborated with notable colleagues such as David S Lawrence and Christopher Albanese, contributing to a rich exchange of ideas and research advancements.

Conclusion

Richard G Pestell's innovative work in cancer research has led to valuable patents that enhance our understanding of cancer treatment and metastasis. His contributions continue to impact the field significantly.